Orally inhaled drug particle deposition efficiency in subjects with two-level laryngotracheal stenosis

D. Frank-Ito (Durham, NC, United States of America)

Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Session: Asthma inhalers: devices and adherence studies
Session type: E-poster session
Number: 3187
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Frank-Ito (Durham, NC, United States of America). Orally inhaled drug particle deposition efficiency in subjects with two-level laryngotracheal stenosis. 3187

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Placing a mask on COVID-19 patients during high-flow nasal cannula therapy reduces aerosol particle dispersion
Source: ERJ Open Res, 7 (1) 00519-2020; 10.1183/23120541.00519-2020
Year: 2021

Extent of inhaled drug deposition at variable inhaler inclination angles and airway geometries: An in-vivo study from a novel computational fluid dynamics model
Source: International Congress 2014 – Asthma and COPD devices and treatments
Year: 2014

Efficient deposition and absorption of orally inhaled indacaterol in the lungs
Source: Annual Congress 2011 - COPD management
Year: 2011

Inhaled long-acting β2-agonist: aerosol particle size and bronchodilator response
Source: Eur Respir J 2005; 26: Suppl. 49, 126s
Year: 2005

In vitro analysis of two formulations of fluticasone/ salmeterol pMDI for delivered dose uniformity and aerodynamic particle size distribution
Source: International Congress 2014 – Rationale behind respiratory drug development
Year: 2014

Improved treatment response to dornase alfa in cystic fibrosis patients using controlled inhalation
Source: Eur Respir J 2011; 38: 1328-1335
Year: 2011

Inhaled corticosteroid fine particle dose from valved holding chambers
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics I
Year: 2010

Effect of paclitaxel delivered nanoparticles to treat tracheal stenosis
Source: International Congress 2015 – Advances in therapeutic bronchoscopy
Year: 2015

Slow particle dissolution may limit lung absorption of inhaled pharmaceuticals in the lungs
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006

Surgical facemask affects fugitive emissions during aerosol drug delivery by high-flow nasal therapy
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021

Precise dosing of five drugs commonly used by patients with cystic fibrosis using an adaptive aerosol delivery system
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008

Improvement of small airway deposition of corticosteroids by smart nebulisation
Source: International Congress 2018 – Asthma and drugs
Year: 2018

A submicron suspension of budesonide improves the mass of ICS delivered during early nebulization
Source: Eur Respir J 2006; 28: Suppl. 50, 712s
Year: 2006

Numerical simulation of the effect of inhalation parameters and disease severity on the deposition of dry powder aerosol drugs in COPD patients
Source: Virtual Congress 2020 – Inhaler devices in COPD: technical advances, adherence studies and more
Year: 2020

Small airway function in asthma patients treated with an ultrafine inhaled steroid aerosol
Source: Eur Respir J 2004; 24: Suppl. 48, 581s
Year: 2004

Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser
Source: Eur Respir J 2007; 30: Suppl. 51, 345s
Year: 2007

Effect of the actuator orifice diameter on the biodisposition of a new budesonide CFC-free metered dose inhaler formulation
Source: Eur Respir J 2001; 18: Suppl. 33, 102s
Year: 2001

Extent of inhaled drug deposition in mouth-throat and pulmonary airways: A novel biophysical modelling approach for inhaled therapeutics
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015

In vitro fine particle dose of drug formulation used in asthma & COPD
Source: Virtual Congress 2020 – Asthma inhalers: devices and adherence studies
Year: 2020

Comparison of systemic bioavailability of two formulations of budesonide nebulized suspension in healthy subjects
Source: Annual Congress 2009 - New aspects of inhalation therapy
Year: 2009